Evaluation and Management of a 20-Month-Old with Cough and Upper-Lobe Rhonchi
For this 20-month-old with cough and rhonchi, you should obtain a chest radiograph immediately and pursue a systematic evaluation for specific causes—particularly protracted bacterial bronchitis (PBB), foreign body aspiration, and pertussis—rather than empirically treating for asthma or reflux. 1
Initial Diagnostic Approach
The presence of rhonchi in a toddler with cough signals potential lower airway involvement and demands investigation for specific etiologies. The 2020 CHEST guidelines explicitly state that common adult causes of chronic cough should not be presumed in children, and management must be age-appropriate 1.
Key Diagnostic Steps:
Obtain a chest radiograph as the first-line imaging study 1. This is a Grade 1B recommendation for any child with chronic cough (>4 weeks), though even shorter duration cough with rhonchi warrants imaging in this age group.
Assess cough characteristics: Determine if the cough is wet/productive versus dry. Wet cough with rhonchi strongly suggests PBB, which is a common and previously under-recognized cause in young children 2.
Consider foreign body aspiration: This is particularly common in toddlers 2. Upper lobe involvement can occur with aspirated objects. Ask specifically about choking episodes, sudden onset of symptoms, or unilateral findings.
Age-Specific Differential Diagnosis
At 20 months, the most likely causes include:
Protracted Bacterial Bronchitis (PBB): Wet cough with rhonchi is the classic presentation. This responds to antibiotics and can be curative 2.
Foreign Body Aspiration: The most common cause of persistent respiratory symptoms in toddlers 2. Upper lobe localization is possible depending on the child's position during aspiration.
Pertussis: If there is paroxysmal cough, post-tussive vomiting, or inspiratory whoop, test for recent Bordetella pertussis infection 1.
Viral bronchitis: Though typically self-limited, can present with rhonchi and cough.
Critical Management Principles
Do NOT empirically treat for asthma, gastroesophageal reflux disease, or upper airway cough syndrome unless specific features of these conditions are present 1. This is a Grade 1A recommendation. The guidelines are emphatic that the empirical "adult approach" of treating these three conditions is inappropriate in children.
What NOT to Do:
- Avoid over-the-counter cough medications (antitussives, mucolytics, antihistamines)—they lack evidence of benefit and carry risk of adverse effects in young children 3, 4
- Do not routinely perform additional tests like CT, bronchoscopy, or allergy testing unless clinically indicated 1
- Spirometry is not age-appropriate for a 20-month-old 1
Treatment Algorithm
If wet cough with rhonchi: Strongly consider PBB and initiate appropriate antibiotic therapy (specific drug, dose, and duration should follow local protocols for PBB) 2.
If chest radiograph shows focal infiltrate or air trapping: Consider foreign body and proceed to flexible bronchoscopy if clinical suspicion is high 1.
If pertussis features present: Obtain PCR testing and consider macrolide therapy 1.
If empirical trial is warranted: Use a defined, limited duration (typically 2-4 weeks) to confirm or refute the diagnosis, then reassess 1.
Environmental Factors
Determine exposure to tobacco smoke and other irritants, and provide cessation counseling to caregivers 1. This is an important exacerbating factor that must be addressed regardless of the underlying cause.
Common Pitfalls
Assuming asthma: At 20 months, asthma is difficult to diagnose definitively. Rhonchi alone do not confirm asthma, and empirical inhaled corticosteroids without other asthma features is not recommended 1.
Missing foreign body: Always maintain high suspicion in toddlers, even without a clear history of choking 2.
Delaying antibiotics for PBB: If wet cough is present, PBB is highly likely and antibiotics can be curative 2.
The systematic, pediatric-specific approach outlined here will identify the cause in approximately 80% of cases, with effective treatment in 90% of diagnosed cases 3.